Molecular mechanisms associated with ALA-PDT of brain tumor cells

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 7380, Issue , 2009, Pages

  Alqawi, Omar ^a   Espiritu, Myrna ^a   Singh, Gurmit ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

acute; ALA; apoptosis; metronomic; PDT; TNF receptors

Indexed keywords

ACUTE; ALA; METRONOMIC; PDT; TNF RECEPTORS;

CELL CULTURE; CELL DEATH; GENES; PLASMONS; POLYMERASE CHAIN REACTION; RNA; TRANSCRIPTION; TRANSCRIPTION FACTORS; TUMORS;

PHOTODYNAMIC THERAPY;

EID: 79959727806     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.823018     Document Type: Conference Paper

References (33)

1. H. Kostron, A. Obwegeser, and R. Jakober, Photodynamic therapy in neurosurgery: a review, J. Photochem. Photobiol. B, 36 (1996) 157-168. (Pubitemid 27011261)
2. A. M. Fisher, A. L. Murphree, and C. J. Gomer, Clinical and preclinical photodynamic therapy, Lasers Surg. Med., 17 (1995) 2-31.
3. L. Lilge and B. C. Wilson, Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers, J. Clin. Laser Med. Surg., 16 (1998) 81-91.
4. Q. Peng, J. Moan, T. Warloe, J. M. Nesland, and C. Rimington, Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma, Int. J. Cancer, 52 (1992) 433-443.
5. Q. Peng, T. Warloe, K. Berg, J. Moan, M. Kongshaug, K. E. Giercksky, and J. M. Nesland, 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges, Cancer, 79 (1997) 2282-2308.
6. S. A. Friesen, G. O. Hjortland, S. J. Madsen, H. Hirschberg, O. Engebraten, J. M. Nesland, and Q. Peng, 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review), Int. J. Oncol., 21 (2002) 577-582.
7. M. S. Patterson, B. C. Wilson, and R. Graff, In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminum chlorosulphonated phthalocyanine, Photochem. Photobiol., 51 (1990) 343-349.
8. L. Lilge, M. Portnoy, and B. C. Wilson, Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue, Br. J. Cancer, 83 (2000) 1110-1117.
9. S. K. Bisland, L. Lilge, A. Lin, R. Rusnov, and B. C. Wilson, Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors, Photochem. Photobiol., 80 (2004) 22-30.
10. Z. Tong, G. Singh, K. Valerie, and A. J. Rainbow, Activation of the stress-activated JNK and p38 MAP kinases in human cells by Photofrin-mediated photodynamic therapy, J. Photochem. Photobiol. B, 71 (2003) 77-85.
11. Z. Tong, G. Singh, and A. J. Rainbow, Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy, Cancer Res., 62 (2002) 5528-5535.
12. J. C. Lee and P. R. Young, Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms, J. Leukoc. Biol., 59 (1996) 152-157. (Pubitemid 26098701)
13. N. L. Oleinick and H. H. Evans, The photobiology of photodynamic therapy: cellular targets and mechanisms, Radiat. Res., 150 (1998) S146-S156. (Pubitemid 28519059)
14. T. J. Dougherty, C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng, Photodynamic therapy, J. Natl. Cancer Inst., 90 (1998) 889-905. (Pubitemid 28304157)
15. D. Kessel and Y. Luo, Mitochondrial photodamage and PDT-induced apoptosis, J. Photochem. Photobiol. B, 42 (1998) 89-95. (Pubitemid 28142328)
16. Z. N. Oltvai and S. J. Korsmeyer, Checkpoints of dueling dimers foil death wishes, Cell, 79 (1994) 189-192.
17. J. C. Reed, Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance, Curr. Opin. Oncol., 7 (1995) 541-546.
18. S. J. Korsmeyer, BCL-2 gene family and the regulation of programmed cell death, Cancer Res., 59 (1999) 1693s- 1700s.
19. M. Srivastava, N. Ahmad, S. Gupta, and H. Mukhtar, Involvement of Bcl-2 and Bax in photodynamic therapymediated apoptosis. Antisense Bcl-2 oligonucleotide sensitizes RIF 1 cells to photodynamic therapy apoptosis, J. Biol. Chem., 276 (2001) 15481-15488.
20. X. Y. Shen, N. Zacal, G. Singh, and A. J. Rainbow, Alterations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cells, Photochem. Photobiol., 81 (2005) 306-313. (Pubitemid 40551506)
21. S. M. Chiu, L. Y. Xue, K. Azizuddin, and N. L. Oleinick, Photodynamic therapy-induced death of HCT 116 cells: Apoptosis with or without Bax expression, Apoptosis., 10 (2005) 1357-1368.
22. B. C. Barnhart, E. C. Alappat, and M. E. Peter, The CD95 type I/type II model, Semin. Immunol., 15 (2003) 185-193. (Pubitemid 38155825)
23. O. Micheau and J. Tschopp, Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes, Cell, 114 (2003) 181-190. (Pubitemid 36936912)
24. E. E. Varfolomeev and A. Ashkenazi, Tumor necrosis factor: an apoptosis JuNKie?, Cell, 116 (2004) 491-497. (Pubitemid 38264427)
25. S. Wang and W. S. El Deiry, TRAIL and apoptosis induction by TNF-family death receptors, Oncogene, 22 (2003) 8628-8633.
26. A. Ashkenazi, Targeting death and decoy receptors of the tumour-necrosis factor superfamily, Nat. Rev. Cancer, 2 (2002) 420-430. (Pubitemid 37328939)
27. L. Y. Xue, S. M. Chiu, and N. L. Oleinick, Photodynamic therapy-induced death of MCF-7 human breast cancer cells: a role for caspase-3 in the late steps of apoptosis but not for the critical lethal event, Exp. Cell Res., 263 (2001) 145-155. (Pubitemid 32989114)
28. S. Eleouet, N. Rousset, J. Carre, L. Bourre, V. Vonarx, Y. Lajat, G. M. Beijersbergen van Henegouwen, and T. Patrice, In vitro fluorescence, toxicity and phototoxicity induced by delta-aminolevulinic acid (ALA) or ALAesters, Photochem. Photobiol., 71 (2000) 447-454.
29. W. Stummer, S. Stocker, A. Novotny, A. Heimann, O. Sauer, O. Kempski, N. Plesnila, J. Wietzorrek, and H. J. Reulen, In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid, J. Photochem. Photobiol. B, 45 (1998) 160-169.
30. C.Wilson, Browning J, Death of HT-29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis , Cell Death and Differen.,9(2002) 1321-1333. (Pubitemid 36097702)
31. H.Wajant, J.Gerspach, K.Pfizenmaier, Tumor therapeutics by design: targeting and activation of death receptors, Cytokine Growth Factor Rev, 16(2005) 55-76.
32. K. Tamada, L.Chen, Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules, Cancer Immunol Immunother., 55(2006) 355-362. (Pubitemid 43076887)
33. G. Bonizzi, M. Karin, The Two NF-κB activition pathways and their role in innate and adaptive immunity, Trends Immunol., 25(2004) 280-288. (Pubitemid 38610351)